2',4'-difluoro-3-(4-methylphenyl)propiophenone, 97.0%, 1g

(4-Chloro-6-methyl-pyrimidin-2-yl)-methyl-amine, 95.0%, 5g

5-(Diethylsulfamoyl)-2-[(2-hydroxyethyl)amino]benzoic acid, 97%, 250mg

2-Bromo-9-N-octyl-9H-carbazole, 98%, 1g

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine, 95.0%, 25g

9-[4-[(1R)-2-Amino-1-methylethyl]phenyl]-8-hydroxy-6-methylthieno[2,3-c]quinolin-4(5H)-one, 5mg

Colonne capillaire GC ROTI®Cap-FFAP, 30 m, 0,25 mm, 0,25 µm, 1 pièce(s)

tert-butyl 3-[(prop-2-en-1-yl)amino]propanoate, 95.0%, 10g

2-(4-Bromo-3-indolyl)acetonitrile, 95%, 1g

Tube d'azote avec cône en verre rodé 14/23, 10 ml, 1 pièce

Ezetimibe>95.0%(T)1g

1,4-Hexadiene (cis- and trans- mixture)>99.0%(GC)5mL

4-Hexylthiophene-2-carbonitrile>95.0%(GC)200mg